Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization

Circulation

Volumn 104, Issue 2, 2001, Pages 163-167

  Lincoff, A Michael ^a   Kereiakes, Dean J ^b   Mascelli, Mary A ^c   Deckelbaum, Lawrence I ^c   Barnathan, Elliot S ^c   Patel, Kamlesh K ^c   Frederick, Bart ^c   Nakada, Marian T ^c   Topol, Eric J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b The Carl & Edyth Lindner Center for Research & Education   (United States)

^c CENTOCOR INC   (United States)

Author keywords

Angioplasty; Inflammation; Platelets

Indexed keywords

ABCIXIMAB; C REACTIVE PROTEIN; FIBRINOGEN RECEPTOR; INTERLEUKIN 6; PLACEBO; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANGIOPLASTY; ARTICLE; BOLUS INJECTION; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; FEMALE; HEART MUSCLE REVASCULARIZATION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0035838353     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.104.2.163     Document Type: Article

References (28)

1. Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty
2. Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina
3. Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary stent implantation
4. Plasma levels of C-reactive protein after coronary stent implantation
5. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease
6. Increasing levels of interleuken (IL)-IRa and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events
7. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina
8. C-reactive protein as a marker for cardiac ischemic events in the year after a first, uncomplicated myocardial infarction
9. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine
10. Platelet glycoprotein IIb/IIIa blockade in coronary artery disease
11. Abciximab (ReoPro, chimeric 7E3 Fab) demonstrates equivalent affinity and functional blockade of glycoprotein IIb/IIIa and avβ3 integrins
12. 7E3 monoclonal antibody directed against the platelet glycoprotein IIb/IIIa cross-reacts with the leukocyte integrin Mac-1 and blocks adhesion to fibrinogen and ICAM-1
13. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty
14. Atherosclerosis: An inflammatory disease
15. Leukocyte adhesion to endothelium in inflammation
16. Oxidatively modified low density lipoproteins: A potential role in recruitment and retention of monocyte/macrophages during atherogenesis
17. Increased expression of matrix matalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques
18. Prospective studies of C-reactive protein as a risk factor for cardiovascular disease
19. Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina
20. Evidence for prevention of death and myocardial infarction with platelet membrane glycoprotein IIb/IIIa receptor blockade by c7E3 Fab (abciximab) among patients with unstable angina undergoing percutaneous coronary revascularization
21. Enhanced survival with platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: One year outcomes and health care economic implications from a multicenter, randomized trial
22. The 1 domain is a major recognition site on the leukocyte integrin Mac-1 (CDI 1b/CD18) for four distinct adhesion ligands
23. Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1-dependent pathway
24. Regulation of leukocyte-endothelium interaction and leukocyte transendothelial migration by intercellular adhesion molecule 1-fibrinogen recognition
25. Neutrophil accumulation on activated, surface-adherent platelets in flow is mediated by interaction of Mac-1 with fibrinogen bound to alpha-IIb beta-3 and stimulated by platelet activating factor
26. Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction
27. Direct proinflammatory effect of C-reactive protein on human endothelial cells
28. C-reactive protein as a cardiovascular risk factor: More than an epiphenomenon?